In particular, gain of function of BRAF plays a critical role in a heterogeneous group of gliomas, as well as in the majority of metastatic melanoma and other cancers (including papillary thyroid cancer, colon carcinomas, hairy cell leukaemia) [25]. The gene discussed is BRAF; the disease is glioma.